PTCB Guide to SSRIs.

What are pharmacy technicians required to learn?

SSRIs are among the most widely prescribed medicines in the United States. Among all antidepressants prescribed, SSRIs remain the most prevalent drug class prescribed in the management of this condition.

For the PTCB exam, pharmacy technicians are required to understand the basic indications, key examples, and essential safety considerations of selective serotonin reuptake inhibitors (SSRIs). These drugs are primarily used to treat depression and anxiety disorders by increasing serotonin levels in the brain.

Technicians should also learn:

• To recognize common side effects (e.g. nausea, insomnia, sexual dysfunction)
• To recognize important risks such as serotonin syndrome, especially when SSRIs are combined with other serotonergic drugs.
• You should also be aware of key drug interactions, such as avoiding combinations with MAO inhibitors or drugs that increase the risk of bleeding (warfarin, antiplatelet drugs etc.).
• To understand that SSRIs may take several weeks to reach full effect.
• Basic knowledge of counseling points, such as not stopping therapy abruptly, is also important.
• To identify brand names from a list of possible drug options.

However, pharmacy technicians are not required to understand detailed pharmacodynamic mechanisms, receptor subtypes, or complex metabolism or precise drug interaction pathways. The focus is on recognition, safety, and practical application in dispensing, rather than in-depth clinical or pharmacological detail.

Key Examples.

There are six key SSRIs technicians should know:

Active ingredient	Brand(s)
Citalopram	Celexa®
Escitalopram	Lexapro®
Sertraline	Zoloft®
Fluoxetine	Prozac®
Fluvoxamine	Luvox® (discontinued) Generic fluvoxamine maleate widely available.
Paroxetine	Paxil®

Key point: notable medicine suffixes here include –etine and –pram, accounting for four of the six SSRIs. (sertraline and fluvoxamine being the only exceptions).

Note also that SSRI drugs are not only used in the treatment of major depressive disorder (MDD). They are also used in the treatment of a range of anxiety disorders, including:

• Generalized anxiety disorder (GAD)
• Social anxiety disorder (SAD)
• Panic disorder
• Obsessive-compulsive disorder (OCD)

Dapoxetine is an exception to the rule, in that the drug is used to treat premature ejaculation (PE) in adult males.

Mechanism of Action.

The exact mechanism of SSRIs is not fully understood.

However, they are known to increase serotonin levels in the brain by inhibiting its reuptake into nerve cells, allowing more serotonin to remain in the synaptic cleft (the space between two nerves).

This increased availability enhances serotonin signaling between neurons, which is associated with improved mood and reduced symptoms of depression and anxiety. By preventing the removal of serotonin and encouraging its reuptake, the mood-elevating properties of serotonin persists longer.

PTCB note: technicians are not required to understand the mechanism of SSRIs beyond this basic concept.

Side Effects.

Common side effects of SSRIs include:

• GI upset
• Headache
• Appetite and weight disturbances
• Suicidal thoughts or behaviors (higher risk in younger patients)
• Increased risk of bleeding
• Increased risk of seizures in susceptible patients
• Sexual dysfunction
• Dizziness
• Dry mouth (xerostomia)
• Serotonin syndrome (at very high doses for prolonged periods)

Note that it may take 6-8 weeks for SSRI drugs to exert their primary clinical effects.

Patients are typically started on a lower dose, with this dose slowly increasing (titrating) over weeks or months. The goal is to establish an optimum dose that produces the greatest clinical effects whilst minimizing the risk of side effects – a tolerable balance between the two outcomes.

Abrupt discontinuation of SSRI drugs is not recommended due to the risk of withdrawal effects. As the brain becomes dependent on the drug, patients must withdraw from the drug over time – with progressively lower doses over a prolonged period.

Sudden withdrawal from SSRI drugs can lead to:

• Sleep disturbances
• Influenza-like symptoms
• Neurological effects
• GI upset / nausea

Drug Interactions and Warnings.

• SSRIs increase the risk of bleeding. Anticoagulant drugs, NSAIDs, and antiplatelet drugs increase this risk. In addition to this, SSRIs increase the risk of bleeding in patients with peptic ulcer disease.
• SSRIs increase the risk of serotonin syndrome. This risk increases when SSRIs are taken with other drugs that elevate serotonin levels, including MAO inhibitors and linezolid.
• SSRIs lower the seizure threshold. There is an increased risk of seizures in patients with epilepsy, or in patients taking other drugs that also lower the seizure threshold (for example: antipsychotic drugs, tramadol, and tricyclic antidepressants).
• SSRIs prolong the QT interval, increasing the risk of cardiac arrhythmias. This risk increases if SSRIs are taken with other drugs that also prolong the QT interval (for example: antipsychotic drugs, fluoroquinolones, lithium, and macrolide antibacterial drugs).

Sample PTCB Exam Questions.

Below you can find five sample PTCB exam questions on the topic of SSRIs.

These five questions reflect the type of questions that get tested about SSRIs on the exam – both the style and difficulty. As always, have a go at the questions yourself before comparing your answers with the explanations (in the section below).

Question 1.

Which statement most accurately describes the mechanism of SSRI antidepressants?

a. SSRIs bind to serotonin receptors on the postsynaptic neuron, directly stimulating serotonin signaling.

b. SSRIs selectively inhibit the reuptake of serotonin into presynaptic neurons, increasing its availability in the synaptic cleft.

c. SSRIs decrease the availability of serotonin between nerve cells of the brain.

d. SSRIs inhibit MAO enzymes, leading to an increased level of serotonin in the synaptic cleft.

Question 2.

What is the active ingredient of the medicine, Zoloft®?

a. Paroxetine

b. Fluvoxamine

c. Escitalopram

d. Sertraline

Question 3.

Which of the following is a notable side effect of SSRIs?

a. Increased alertness

b. Increased risk of bleeding

c. Increased libido

d. Decreased risk of seizures

Question 4.

When taken with SSRIs, which drug class increases the risk of serotonin syndrome?

a. NSAIDs

b. Mild opioid analgesics

c. ACE inhibitors

d. MAO inhibitors

Question 5.

A patient approaches the pharmacy counter and mentions they are currently taking citalopram. They report experiencing mild side effects, including dizziness and xerostomia, and ask for a recommendation to relieve the xerostomia.

As a pharmacy technician, you should recognize that xerostomia refers to:

a. Blurred vision

b. Dry mouth

c. Muscle weakness

d. Difficulty sleeping

Answer Explanations.

Answer to Question 1 – b. SSRIs selectively inhibit the reuptake of serotonin into presynaptic neurons, increasing its availability in the synaptic cleft.

More serotonin inside the synaptic cleft (the space between two nerves) means greater neurotransmission = reduced depression and symptom severity.

Answer to Question 2 – d. Sertraline

Sertraline is the active ingredient of the medicine, Zoloft®.

Answer to Question 3 – b. Increased risk of bleeding

SSRIs increase the risk of bleeding. This risk increases when taken with NSAIDs, antiplatelet drugs, or anticoagulant drugs. This risk is higher in patients with active peptic ulcer disease.

Answer to Question 4 – d. MAO inhibitors

MAO inhibitors increase the risk of serotonin syndrome if taken with SSRI antidepressants. Serotonin syndrome is a serious condition where there is too much serotonin in the body. It can cause symptoms such as shaking, confusion, fever, and a fast heartbeat. It requires urgent medical attention.

Answer to Question 5 – b. Dry mouth

Xerostomia is the medical term for dry mouth. SSRIs are a common drug-induced cause of xerostomia.

PTCB Cheat Sheet – SSRIs.

• SSRI drugs are used in the treatment of major depressive disorder, as well as a range of anxiety disorders.
• Examples include fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, and escitalopram.
• Key drug suffixes: –etine and –pram, accounting for four of the six main SSRIs.
• SSRIs work by increasing serotonin levels in the brain in the synaptic cleft. More serotonin in the space between two nerves means more neurotransmission = elevated mood and reduce symptom severity.
• Side effects of SSRIs include dizziness, dry mouth (xerostomia), reduced libido, increased risk of bleeding, prolongation of the QT interval, headache, appetite and weight disturbances, GI upset, and serotonin syndrome.
• NSAIDs, antiplatelet drugs, and anticoagulant drugs (such as warfarin) increase the risk of bleeding. Risk of bleeding is higher in patients with peptic ulcer disease.
• Antipsychotic drugs increase the risk of both seizures and cardiac arrhythmias when taken with SSRIs.
• MAO inhibitors and linezolid increase the risk of serotonin syndrome.
• SSRIs should not be suddenly withdrawn due to the risk of withdrawal effects. They should be withdrawn over a period of time, with the oversight of the patient’s prescriber.

Hope you found this week’s PTCB guide to SSRIs useful!

Master this & every other topic of the PTCB exam by becoming a full member of our test prep program – all the features and course materials need to pass the PTCB exam on your first attempt.